54 related articles for article (PubMed ID: 11857074)
1. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Oncogene; 2002 Feb; 21(9):1309-15. PubMed ID: 11857074
[TBL] [Abstract][Full Text] [Related]
2. Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.
Tanaka T; Sewell H; Waters S; Phillips SE; Rabbitts TH
J Biol Chem; 2011 Feb; 286(5):3707-16. PubMed ID: 20980262
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils: key mediators of tumour angiogenesis.
Tazzyman S; Lewis CE; Murdoch C
Int J Exp Pathol; 2009 Jun; 90(3):222-31. PubMed ID: 19563607
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis.
Yamada Y; Zhong Y; Miki S; Taura A; Rabbitts TH
Sci Rep; 2022 May; 12(1):7226. PubMed ID: 35508511
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.
Duddu S; Chakrabarti R; Ghosh A; Shukla PC
Front Genet; 2020; 11():588602. PubMed ID: 33193725
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2.
Milton-Harris L; Jeeves M; Walker SA; Ward SE; Mancini EJ
Oncotarget; 2020 May; 11(19):1737-1748. PubMed ID: 32477463
[TBL] [Abstract][Full Text] [Related]
7. Network analysis of DEGs and verification experiments reveal the notable roles of PTTG1 and MMP9 in lung cancer.
Xu X; Cao L; Zhang Y; Yin Y; Hu X; Cui Y
Oncol Lett; 2018 Jan; 15(1):257-263. PubMed ID: 29387220
[TBL] [Abstract][Full Text] [Related]
8. Hybrid Method Based on Information Gain and Support Vector Machine for Gene Selection in Cancer Classification.
Gao L; Ye M; Lu X; Huang D
Genomics Proteomics Bioinformatics; 2017 Dec; 15(6):389-395. PubMed ID: 29246519
[TBL] [Abstract][Full Text] [Related]
9. LMO2 (LIM Domain Only 2) and Endothelial Cell Migration in Developmental and Postnatal Angiogenesis.
Ganta VC; Annex BH
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1806-1808. PubMed ID: 28954807
[No Abstract] [Full Text] [Related]
10. LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration.
Meng S; Matrone G; Lv J; Chen K; Wong WT; Cooke JP
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792641
[TBL] [Abstract][Full Text] [Related]
11. LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer).
Simonik EA; Cai Y; Kimmelshue KN; Brantley-Sieders DM; Loomans HA; Andl CD; Westlake GM; Youngblood VM; Chen J; Yarbrough WG; Brown BT; Nagarajan L; Brandt SJ
PLoS One; 2016; 11(10):e0164804. PubMed ID: 27780223
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential therapeutic targets for lung cancer by bioinformatics analysis.
Wang LQ; Zhao LH; Qiao YZ
Mol Med Rep; 2016 Mar; 13(3):1975-82. PubMed ID: 26739332
[TBL] [Abstract][Full Text] [Related]
13. LMO2 at 25 years: a paradigm of chromosomal translocation proteins.
Chambers J; Rabbitts TH
Open Biol; 2015 Jun; 5(6):150062. PubMed ID: 26108219
[TBL] [Abstract][Full Text] [Related]
14. GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.
Coma S; Allard-Ratick M; Akino T; van Meeteren LA; Mammoto A; Klagsbrun M
Angiogenesis; 2013 Oct; 16(4):939-52. PubMed ID: 23892628
[TBL] [Abstract][Full Text] [Related]
15. LIM-domain-only proteins in cancer.
Matthews JM; Lester K; Joseph S; Curtis DJ
Nat Rev Cancer; 2013 Feb; 13(2):111-22. PubMed ID: 23303138
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.
Dastmalchi S; Wilkinson-White L; Kwan AH; Gamsjaeger R; Mackay JP; Matthews JM
Protein Sci; 2012 Nov; 21(11):1768-74. PubMed ID: 22936624
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
18. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
Cubedo E; Gentles AJ; Huang C; Natkunam Y; Bhatt S; Lu X; Jiang X; Romero-Camarero I; Freud A; Zhao S; Bacchi CE; Martínez-Climent JA; Sánchez-García I; Melnick A; Lossos IS
Blood; 2012 Jun; 119(23):5478-91. PubMed ID: 22517897
[TBL] [Abstract][Full Text] [Related]
19. The regulatory epicenter of miRNAs.
Jha A; Mehra M; Shankar R
J Biosci; 2011 Sep; 36(4):621-38. PubMed ID: 21857109
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
Gratzinger D; Zhao S; West R; Rouse RV; Vogel H; Gil EC; Levy R; Lossos IS; Natkunam Y
Am J Clin Pathol; 2009 Feb; 131(2):264-78. PubMed ID: 19141387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
